Cantor Fitzgerald analyst Alethia Young ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Hot Comments

Ascendis Pharma (ASND) Prices 4.166M ADS Offering at $120/ADSMarch 6, 2019 5:57 AM Ascendis Pharma (ASND) Reports Positive Top-Line Results from Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency, Demonstrating Superiority on Primary EndpointMarch 4, 2019 6:35 AM Form 6-K Ascendis Pharma A/S For: Mar 04March 4, 2019 6:32 AM Ascendis Pharma Announces Once-weekly TransCon™ Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone DeMarch 4, 2019 6:30 AM